Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone and Alpha-Interferon in AL Amyloidosis
NCT00002849Phase 2Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Nov 1996
- Primary completion
- Dec 1998
- Modality
- Orthosteric Ligands, Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of dexamethasone, interferon alfa in primary systemic amyloidosis, sponsored by SWOG Cancer Research Network. Started Nov 1996; status: completed.
02
Drugs
dexamethasoneinterferon alfa
03
Conditions
primary systemic amyloidosis
Beyond the preview
Go deeper on NCT00002849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002849.